Search - tctmd.com

Displaying 501 - 520 of 1574

Sort: Relevancy | Date

Presentation TCT 2021

Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective

Presenter: Andrew Farb

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

Presentation TCT 2021

EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

Presenter: Haibo Jia

November 04, 2021

News Conference News TCT 2021

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Shelley Wood

November 04, 2021

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

Presentation TCT 2021

FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

Presenter: Bo Xu

November 04, 2021

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

Presentation TCT 2021

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

Presenter: William Fearon

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes

Presenter: Matthias Lutz

November 04, 2021

Presentation TCT 2021

Prasugrel De-escalation Therapy After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Subgroup Analysis of the HOST-REDUCE-POLYTECH-ACS Randomized Clinical Trial

Presenter: Doyeon Hwang

November 04, 2021

Presentation TCT 2021

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Presenter: Mario Gaudino

November 04, 2021

Presentation TCT 2021

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Presenter: Christopher Rajkumar

November 04, 2021

Presentation TCT 2021

Breaking the Small-Bore Barrier

Presenter: Amir Kaki

November 04, 2021

Presentation TCT 2021

Door to Unload: Implications for STEMI, HR-PCI and Cardiogenic Shock

Presenter: Navin Kapur

November 04, 2021

Presentation TCT 2021

Real World Evidence leading to RECOVER IV

Presenter: William O'Neill

November 04, 2021

Presentation TCT 2021

PROTECT Series leading to PROTECT IV

Presenter: Gregg Stone

November 04, 2021

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Shelley Wood

November 01, 2021

Advertisement

Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

FAVOR III China Adds Strength to Value of QFR-Guided PCI

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes

Prasugrel De-escalation Therapy After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Subgroup Analysis of the HOST-REDUCE-POLYTECH-ACS Randomized Clinical Trial

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Breaking the Small-Bore Barrier

Door to Unload: Implications for STEMI, HR-PCI and Cardiogenic Shock

Real World Evidence leading to RECOVER IV

PROTECT Series leading to PROTECT IV

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content